Back to video list Back to Home The Evolution of Pharmacological Treatments and Treatment Goals in MDD and Anxiety You may also like Alzheimer's Disease Satellite symposium Article New insights into the role of neuroinflammation in Alzheimer’s disease Bipolar Schizophrenia Article Dopamine synthesis is the common factor in genetic and environmental risks in schizophrenia Schizophrenia Article Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden Mental Health Article New findings in aging, pain, depression, suicide, anxiety and schizophrenia